tradingkey.logo
tradingkey.logo
Search

TRUP

TRUP
Add to Watchlist
24.490USD
+0.010+0.04%
Close 07-31 16:00ETQuotes delayed by 15 min
1.07BMarket Cap
40.87P/E TTM

TradingKey Stock Score of TRUP

Currency: USD Updated: 2026-07-31

Key Insights

's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 21 out of 114 in the Insurance industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 37.25.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

TRUP's Score

Industry at a Glance

Industry Ranking
21 / 114
Overall Ranking
119 / 4281
Industry
Insurance

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Positive

TRUP Highlights

StrengthsRisks
Trupanion, Inc. is a medical insurance provider for cats and dogs throughout the United States, Canada, certain countries in Continental Europe, and Australia. The Company operates in two segments, namely, Subscription Business and Other Business. The Subscription Business segment includes subscription fees related to the Company's direct-to-consumer products. The Other Business segment comprises other product offerings that generally have a business-to-business relationship and a different margin profile than its subscription segment, including writing policies on behalf of third parties and other products and software solutions. It offers Trupanion, software that is designed to communicate directly with veterinary hospital's practice management software. It provides Powered by Trupanion pet insurance product offerings marketed by third parties and marketed under the brand names Furkin and PHI Direct in Canada, and a Trupanion branded product in Germany and Switzerland.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 29.83% year-on-year.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Undervalued
The company’s latest PE is 40.87, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 42.39M shares, decreasing 5.11% quarter-over-quarter.
Held by Paul Tudor Jones
Star Investor Paul Tudor Jones holds 372.06K shares of this stock.

Analyst Rating

Based on 6 analysts
Buy
Current Rating
54.750
Target Price
+46.90%
Upside Space
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.